System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Charles De Carli is an expert in Neurology at University of California Davis Medical Center (United States). As of October 2026, ScienceLeadR ranks Charles De Carli in the top 1% of experts worldwide for Cognitive Dysfunction, Cognition Disorders and Neurocognitive Disorders. Charles De Carli has authored 1,533 publications, the most recent in 2026, and is an investigator in 8 clinical trials, 1 of them ongoing. SLR score: 5,082 (community average: 125). How the SLR is computed.

LeadR Profile

Charles De Carli University of California Davis Medical Center United States
5 082 ScienceLeadR Reputation 5082

Unlock

Register Login
Network Map

Neurology

Subspecialties: Psychiatry - Cardiology - Genetics

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1996 - 2026
Source: PubMed

University of California, Davis

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 1533

Citations

Citations: 127 182 1st author: 66 Last author: 178 Unique author: 24

Main journals

Alzheimers Dement 365
Neurology 134
Stroke 93
J Alzheimers Dis 44
Neurobiol Aging 44

Best Journals

JAMA 6
N Engl J Med 4
Circulation 3

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Regional distribution of mineralized blood vessels in Alzheimer disease and clinicopathological associations: A multicenter autopsy study.
PMID 42805035 — hippocampus, blood, globus pallidus, alzheimer disease, aging, putamen, sex, blood vessels, autopsy		Neurobiol Aging20260
Correction to: Oxygen extraction fraction mapping between normal cognition and mild cognitive impairment in older adults using quantitative BOLD.
PMID 42903549 — cognitive dysfunction, cognition disorders, cognition		Imaging Neurosci (Camb)20260
Location matters: Attributing cognitive symptoms to white matter hyperintensities in 3,481 memory clinic patients.
PMID 42895925 — white matter, neurobehavioral manifestations, executive function, signs and symptoms, cognition disorders, sex, memory, cognition, demography		Dement Geriatr Cogn Disord20260
Role of APOE ɛ4 and ɛ2 With Longitudinal Cognitive Decline Among Those With Exceptional Longevity: The LifeAfter90 Study.
PMID 42886871 — mortality, longevity, cognitive dysfunction, aged, genotype, apolipoproteins e, memory, neurology		Neurology20261
Multimodal MRI insights into glymphatic clearance and blood-brain barrier integrity in healthy aging.
PMID 42857575 — white matter, blood-brain barrier, blood, glymphatic system, aging, brain, diffusion tensor imaging, healthy aging		Imaging Neurosci (Camb)20260

Clinical Studies 8

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 3
Phase 3 3
Phase 1 1
Phase 2 1

By status:

Completed 7
Active not recruiting 1

By type:

Interventional 6
Observational 2

By Monocentric/Multicentric:

monocentric 1
multicentric2to4 0
multicentric5to9 1
multicentricup10 6

Main Topics

Cohort/Consortium Investigators 67

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Biomarkers for Vascular Contributions to Cognitive Impairment and Dementia Consortium
NCT06284213 — dementia, blood, brain, cognitive dysfunction, biomarkers, cognition disorders, research, memory		N/AActive not recruiting2021

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS